The Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate Immunity

Area of Science:

• Membrane Biology
• Innate Immunity
• Lipid Metabolism

Background:

• Lipid metabolism and receptor signaling are crucial for cellular homeostasis.
• Toll-like receptors (TLRs) initiate complex inflammatory responses requiring tight regulation.

Purpose of the Study:

• To identify novel regulators of TLR signaling at the interface of membrane biology and innate immunity.
• To investigate the role of Sphingomyelin Phosphodiesterase, Acid-Like 3B (SMPDL3B) in TLR-mediated inflammatory responses.

Main Methods:

• Mass spectrometry to identify membrane proteins co-purifying with TLRs.
• Macrophage assays to assess TLR responsiveness and lipid composition in Smpdl3b-deficient cells.
• In vivo studies using Smpdl3b-deficient mice in TLR-dependent peritonitis models.

Main Results:

• SMPDL3B was identified as a membrane protein associated with TLRs.
• Smpdl3b deficiency enhanced macrophage responsiveness to TLR stimulation, altering lipid composition and membrane fluidity.
• Reintroduction of ceramides restored normal cellular responses.
• Smpdl3b-deficient mice exhibited heightened inflammatory responses in vivo.

Conclusions:

• SMPDL3B acts as a negative regulator of TLR signaling.
• The enzyme functions at the intersection of membrane lipid metabolism and innate immune responses.
• SMPDL3B is a critical modulator of inflammatory processes.